Ilaria Gori

Ilaria Gori

Auto-generated profile, based on publicly available information

Ilaria Gori

Developmental Signalling Laboratory The Francis Crick Institute London UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ARAnassuya Ramachandran
Anassuya Ramachandran
MMMerima Mehić
Merima Mehić
LWLaabiah Wasim
Laabiah Wasim
DMDessislava Malinova
Dessislava Malinova
IGIlaria Gori
Ilaria Gori
CHCaroline S Hill
Caroline S Hill
Fibrodysplasia ossificans progressiva (FOP) and diffuse intrinsic pontine glioma (DIPG) are debilitating diseases that share causal mutations in ACVR1, a TGF‐β family type I receptor. ACVR1 R206H is a frequent mutation in both diseases. Pathogenic signaling via the SMAD1/5 pathway is mediated by Activin A, but how the mutation triggers aberrant signaling is not known. We show that ACVR1 is essential for Activin A‐mediated SMAD1/5 phosphorylation and is activated by two distinct mechanisms. Wild‐type ACVR1 is activated by the Activin type I receptors, ACVR1B/C. In contrast, ACVR1 R206H activation does not require upstream kinases, but is predominantly activated via Activin A‐dependent receptor clustering, which induces its auto‐activation. We use optogenetics and live‐imaging approaches to demonstrate Activin A‐induced receptor clustering and show it requires the type II receptors ACVR2A/B. Our data provide molecular mechanistic insight into the pathogenesis of FOP and DIPG by linking the causal activating genetic mutation to disrupted signaling.

8 January 2021 in eLife
Verified
Journal Article
Open access
IGIlaria Gori
Ilaria Gori
RGRoger George
Roger George
APAndrew G Purkiss
Andrew G Purkiss
SSStephanie Strohbuecker
Stephanie Strohbuecker
RRRebecca A Randall
Rebecca A Randall
CHCaroline S Hill
Caroline S Hill
Shprintzen–Goldberg syndrome (SGS) is a multisystemic connective tissue disorder, with considerable clinical overlap with Marfan and Loeys–Dietz syndromes. These syndromes have commonly been associated with enhanced TGF-β signaling. In SGS patients, heterozygous point mutations have been mapped to the transcriptional co-repressor SKI, which is a negative regulator of TGF-β signaling that is rapidly degraded upon ligand stimulation. The molecular consequences of these mutations, however, are not understood. Here we use a combination of structural biology, genome editing, and biochemistry to show that SGS mutations in SKI abolish its binding to phosphorylated SMAD2 and SMAD3. This results in stabilization of SKI and consequently attenuation of TGF-β responses, both in knockin cells expressing an SGS mutation and in fibroblasts from SGS patients. Thus, we reveal that SGS is associated with an attenuation of TGF-β-induced transcriptional responses, and not enhancement, which has important implications for other Marfan-related syndromes.

19 November 2026 in medRxiv
Verified
Preprint
Open access
ODOlli Dufva
Olli Dufva
SLShuang Li
Shuang Li
JPJ. Patrick Pett
J. Patrick Pett
ALArianna Landini
Arianna Landini
DZDaniela Zanotti
Daniela Zanotti
STSarah A. Teichmann
Sarah A. Teichmann
The cellular composition of blood is fundamental to human physiology and is routinely measured to assess health and disease. Circulating immune cells show extensive heterogeneity, but the organising principles and extremes of variation across individuals remain undefined. Here, using single-cell transcriptomics across two biobank cohorts encompassing ~6,000 individuals, we show that human blood occupies recurrent archetypal states defined by coordinated cell composition patterns. We delineate three major archetypes spanning naive lymphoid, myeloid and cytotoxic composition, and two minor archetypes characterised by type I interferon-driven inflammation and expanded premalignant CD5+ B cells. We develop cell2clone to infer lymphocyte clonal expansions, revealing how reactive clonal processes drive the cytotoxic archetype and premalignant clonal expansion establishes the CD5+ B cell archetype, creating outlier states that uncover context-specific effects of germline variants. Clonal haematopoiesis and mosaic chromosomal alterations influence blood states in an archetype-dependent manner. The archetype framework links blood states to common disease risk and clinical blood counts and, through a machine-learning model ArcheTypist, classifies infection and cancer immunotherapy outcomes. This population-scale framework has implications for diagnostics, early disease detection, immunotherapy stratification and mechanistic insights into disease susceptibility and therapy response, providing an organising model for identifying compositional subtypes across human tissues.